The creation and implementation of an outpatient pulmonary embolism treatment protocol

References

• Barnes GD, Gafoor S, Wakefield T, et al. National trends in venous disease. J Vasc Surg. 2010;51(6):1467–1473.
   PubMed Web of Science ®Google Scholar
• Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Thrombolysis. 2016;41(1):3–14.
   PubMed Web of Science ®Google Scholar
• Smith SB, Geske JB, Kathuria P, et al. Analysis of national trends in admissions for pulmonary embolism. Chest. 2016;150(1):35–45.
   PubMed Web of Science ®Google Scholar
• Becattini C, Agnelli G. Predictors of mortality from pulmonary embolism and their influence on clinical management. Thromb Haemost. 2008;100(5):747–751.
   PubMed Web of Science ®Google Scholar
• Stein PD, Matta F, Alrifai A, et al. Trends in case fatality rate in pulmonary embolism according to stability and treatment. Thromb Res. 2012;130(6):841–846.
   PubMed Web of Science ®Google Scholar
• Singer AJ, Thode HC Jr., Peacock W. Admission rates for emergency department patients with venous thromboembolism and estimation of the proportion of low risk pulmonary embolism patients: a US perspective. Clin Exp Emerg Med. 2016;3(3):126–131.
   PubMed Web of Science ®Google Scholar
• Aujesky D, Perrier A, Roy PM, et al. Validation of a clinical prognostic model to identify low-risk patients with pulmonary embolism. J Intern Med. 2007;261(6):597–604.
   PubMed Web of Science ®Google Scholar
• Becattini C, Agnelli G. Risk stratification and management of acute pulmonary embolism. Hematology Am Soc Hematol Educ Program. 2016;2016(1):404–412.
   PubMedGoogle Scholar
• Kabrhel C, Okechukwu I, Hariharan P, et al. Factors associated with clinical deterioration shortly after PE. Thorax. 2014;69(9):835–842.
   PubMed Web of Science ®Google Scholar
• Weeda ER, Kohn CG, Peacock WF, et al. External validation of the hestia criteria for identifying acute pulmonary embolism patients at low risk of early mortality. Clin Appl Thromb Hemost. 2016. PMID:27225840. [Epub ahead of print]
   Google Scholar
• Aujesky D, Roy PM, Verschuren F, et al. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet. 2011;378(9785):41–48.
   PubMed Web of Science ®Google Scholar
• Stein PD, Matta F, Hughes MJ. National trends in home treatment of acute pulmonary embolism. Clin Appl Thromb Hemost. 2016. PMID:27789604. [Epub ahead of print]
   PubMedGoogle Scholar
• Kline JA, Kahler ZP, Beam DM. Outpatient treatment of low-risk venous thromboembolism with monotherapy oral anticoagulation: patient quality of life outcomes and clinician acceptance. Patient Prefer Adherence. 2016;10:561–569.
   PubMed Web of Science ®Google Scholar
• Kovacs MJ, Anderson D, Morrow B, et al. Outpatient treatment of pulmonary embolism with dalteparin. Thromb Haemost. 2000;83(2):209–211.
   PubMed Web of Science ®Google Scholar
• Wells PS. Outpatient treatment of patients with deep-vein thrombosis or pulmonary embolism. Curr Opin Pulm Med. 2001;7(5):360–364.
   PubMedGoogle Scholar
• Wells PS, Buller HR. Outpatient treatment of patients with pulmonary embolism. Semin Vasc Med. 2001;1(2):229–234.
   PubMedGoogle Scholar
• Piran S, Le Gal G, Wells PS, et al. Outpatient treatment of symptomatic pulmonary embolism: a systematic review and meta-analysis. Thromb Res. 2013;132(5):515–519.
   PubMed Web of Science ®Google Scholar
• Vinson DR, Zehtabchi S, Yealy DM, Can selected patients with newly diagnosed pulmonary embolism be safely treated without hospitalization? A systematic review. Ann Emerg Med. 2012;605:651–662. e654
   PubMed Web of Science ®Google Scholar
• Yoo HH, Queluz TH, El Dib R. Outpatient versus inpatient treatment for acute pulmonary embolism. Cochrane Database Syst Rev. 2014 Nov 20;(11):CD010019. doi:10.1002/14651858.CD010019.pub2.
   Web of Science ®Google Scholar
• Donze J, Le Gal G, Fine MJ, et al. Prospective validation of the pulmonary embolism severity index. A clinical prognostic model for pulmonary embolism. Thromb Haemost. 2008;100(5):943–948.
   PubMed Web of Science ®Google Scholar
• Jimenez D, Aujesky D, Moores L, et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010;170(15):1383–1389.
   PubMedGoogle Scholar
• Stein PD, Hull RD, Matta F, et al. Early discharge of patients with venous thromboembolism: implications regarding therapy. Clin Appl Thromb Hemost. 2010;16(2):141–145.
   PubMed Web of Science ®Google Scholar
• Aujesky D, Obrosky DS, Stone RA, et al. A prediction rule to identify low-risk patients with pulmonary embolism. Arch Intern Med. 2006;166(2):169–175.
   PubMedGoogle Scholar
• Giannitsis E, Muller-Bardorff M, Kurowski V, et al. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation. 2000;102(2):211–217.
   PubMed Web of Science ®Google Scholar
• Janata K, Holzer M, Laggner AN, et al. Cardiac troponin T in the severity assessment of patients with pulmonary embolism: cohort study. BMJ. 2003;326(7384):312–313.
   PubMed Web of Science ®Google Scholar
• La Vecchia L, Ottani F, Favero L, et al. Increased cardiac troponin I on admission predicts in-hospital mortality in acute pulmonary embolism. Heart. 2004;90(6):633–637.
   PubMed Web of Science ®Google Scholar
• Vinson DR, Drenten CE, Huang J, et al. Impact of relative contraindications to home management in emergency department patients with low-risk pulmonary embolism. Ann Am Thorac Soc. 2015;12(5):666–673.
   PubMedGoogle Scholar
• Becattini C, Agnelli G, Lankeit M, et al. Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model. Eur Respir J. 2016;48(3):780–786.
   PubMed Web of Science ®Google Scholar
• Zondag W, Mos IC, Creemers-Schild D, et al. Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study. J Thromb Haemost. 2011;9(8):1500–1507.
   PubMed Web of Science ®Google Scholar
• Becattini C, Cohen AT, Agnelli G, et al. Risk stratification of patients with acute symptomatic pulmonary embolism based on presence or absence of lower extremity DVT: systematic review and meta-analysis. Chest. 2016;149(1):192–200.
   PubMed Web of Science ®Google Scholar
• Investigators E, Bauersachs R, Berkowitz SD, et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010;363(26):2499–2510.
   PubMed Web of Science ®Google Scholar
• Agnelli G, Buller HR, Cohen A, et al. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med. 2013;369(9):799–808.
   PubMed Web of Science ®Google Scholar
• Hariharan P, Dudzinski DM, Rosovsky R, et al. Relation among clot burden, right-sided heart strain, and adverse events after acute pulmonary embolism. Am J Cardiol. 2016;118(10):1568–1573.
   PubMed Web of Science ®Google Scholar
• Dudzinski DM, Hariharan P, Parry BA, et al. Assessment of right ventricular strain by computed tomography versus echocardiography in acute pulmonary embolism. Acad Emerg Med. 2017 Mar;24(3):337–343. PMID:27664798. doi:10.1111/acem.13108.
   PubMed Web of Science ®Google Scholar
• Pomero F, Dentali F, Borretta V, et al. Accuracy of emergency physician-performed ultrasonography in the diagnosis of deep-vein thrombosis: a systematic review and meta-analysis. Thromb Haemost. 2013;109(1):137–145.
   PubMed Web of Science ®Google Scholar
• Provias T, Dudzinski DM, Jaff MR, et al. The Massachusetts General Hospital Pulmonary Embolism Response Team (MGH PERT): creation of a multidisciplinary program to improve care of patients with massive and submassive pulmonary embolism. Hosp Pract (1995). 2014;42(1):31–37.
   PubMedGoogle Scholar
• Kabrhel C, Rosovsky R, Channick R, et al. A multidisciplinary pulmonary embolism response team: initial 30-month experience with a novel approach to delivery of care to patients with submassive and massive pulmonary embolism. Chest. 2016;150(2):384–393.
   PubMed Web of Science ®Google Scholar
• Ahmed Z, Hassan S, Salzman GA. Novel oral anticoagulants for venous thromboembolism with special emphasis on risk of hemorrhagic complications and reversal agents. Curr Drug Ther. 2016;11(1):3–20.
   PubMed Web of Science ®Google Scholar
• Pignataro BS, Nishinari K, Cavalcante RN, et al. Oral rivaroxaban for the treatment of symptomatic venous thromboembolism in 400 patients with active cancer. Clin Appl Thromb Hemost. 2016 Jan 1. PMID:28027659. doi:10.1177/1076029616677800. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Lee AY, Carrier M. Treatment of cancer-associated thrombosis: perspectives on the use of novel oral anticoagulants. Thromb Res. 2014;133(Suppl 2):S167–S171.
   PubMed Web of Science ®Google Scholar
• Agnelli G, Buller HR, Cohen A, et al. Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial. J Thromb Haemost. 2015;13(12):2187–2191.
   PubMed Web of Science ®Google Scholar
• Akl EA, Vasireddi SR, Gunukula S, et al. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. Cochrane Database Syst Rev. 2014 Jun 19;(6):CD006649. PMID:24945634. doi:10.1002/14651858.CD006649.pub6.
   Web of Science ®Google Scholar
• Malec K, Goralczyk T, Undas A. The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome. Thromb Res. 2017 Apr;152:93–97. PMID:27989533.
   PubMed Web of Science ®Google Scholar
• Hicks LK, Bering H, Carson KR, et al. The ASH choosing wisely(R)campaign: five hematologic tests and treatments to question. Hematology Am Soc Hematol Educ Program. 2013;2013:9–14.
   PubMedGoogle Scholar
• Vandiver JW, Ritz LI, Lalama JT. Chemical prophylaxis to prevent venous thromboembolism in morbid obesity: literature review and dosing recommendations. J Thromb Thrombolysis. 2016;41(3):475–481.
   PubMed Web of Science ®Google Scholar
• Thompson-Moore NR, Wanat MA, Putney DR, et al. Evaluation and pharmacokinetics of treatment dose enoxaparin in hospitalized patients with morbid obesity. Clin Appl Thromb Hemost. 2015;21(6):513–520.
   PubMed Web of Science ®Google Scholar